A new pancreatic adenocarcinoma‐derived organoid model of acquired chemoresistance to FOLFIRINOX: first insight of the underlying mechanisms
Univ. Lille, CNRS, Inserm, CHU Lille, UMR9020-U1277 - CANTHER – Cancer Heterogeneity Plasticity and Resistance to Therapies, Lille, F-59000 France
OrgaRES consortium: Christophe Mariette, Guillaume Piessen, François Corfiotti, Clarisse Eveno, François-René Pruvot, Stéphanie Truant, Mehdi El Amrani, Emmanuelle Leteurtre, Florence Renaud, Viviane Gnemmi, Laurence Wicquart, Fabienne Escande, Julie Leclerc, Sonia Paget, Soumaya El Moghrabi, Audrey Vincent, Isabelle Van Seuningen
Search for more papers by this author
Comments (0)